Intersect ENT, a subsidiary of Medtronic,[5] is a health care equipment company based in Menlo Park, California.

[1] It was originally headquartered in Palo Alto, California, then moved to Menlo Park, CA in April 2012 to a new 32,000-foot facility.

In 2013, it received $30 million in a series D round of financing led by Norwest Venture Partners, and included all named investors.

Intersect ENT received FDA pre-market approval for Propel in August 2011 and for a mini version in November 2012.

[15][16] In 2014, it began clinical studies for its RESOLVE device, an in-office treatment for chronic sinusitis, designed to be an alternative to surgery and oral steroid pills.